(Q46226739)

20 December 2017

title

Absence of relationship between steroid hormone levels and prostate cancer tumor grade (English)

1 reference

20 December 2017

1 reference

6

1 reference

20 December 2017

Meredith M Regan

4

object named as

Meredith M Regan

1 reference

20 December 2017

author name string

David J Sher

1

1 reference

20 December 2017

Christos Mantzoros

2

1 reference

20 December 2017

Susanna Jacobus

3

1 reference

20 December 2017

Gwo-Shu Lee

5

1 reference

20 December 2017

language of work or name

English

0 references

publication date

26 November 2008

1 reference

20 December 2017

published in

Urology

1 reference

20 December 2017

volume

73

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

356-61; discussion 361-2

1 reference

20 December 2017

STUDIES ON PROSTATIC CANCER

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.068

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.068

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.068

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.068

High-grade prostate cancer is associated with low serum testosterone levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.068

Is low serum free testosterone a marker for high grade prostate cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.068

Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.068

Development of an integrated prostate cancer research information system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.068

Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.068

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.068

Association between the dihydrotestosterone level in the prostate and prostate cancer aggressiveness using the Gleason score

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.068

Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.068

The association of time of day and serum testosterone concentration in a large screening population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.07.068

10.1016/J.UROLOGY.2008.07.068

7 January 2021

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017